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Abstract
Head and neck squamous cell carcinoma is one of the most aggressive tumours and is typi-
cally diagnosed too late. Late diagnosis requires an urgent decision on an effective therapy.
An individualized test of chemosensitivity should quickly indicate the suitability of chemo-
therapy and radiotherapy. No ex vivo chemosensitivity assessment developed thus far has
become a part of general clinical practice. Therefore, we attempted to explore the new tech-
nique of coherence-controlled holographic microscopy to investigate the motility and growth
of live cells from a head and neck squamous cell carcinoma biopsy. We expected to reveal
behavioural patterns characteristic for malignant cells that can be used to imrove future pre-
dictive evaluation of chemotherapy. We managed to cultivate primary SACR2 carcinoma
cells from head and neck squamous cell carcinoma biopsy verified through histopathology.
The cells grew as a cohesive sheet of suspected carcinoma origin, and western blots
showed positivity for the tumour marker p63 confirming cancerous origin. Unlike the round-
ish colonies of the established FaDu carcinoma cell line, the SACR2 cells formed irregularly
shaped colonies, eliciting the impression of the collective invasion of carcinoma cells. Time-
lapse recordings of the cohesive sheet activity revealed the rapid migration and high plastic-
ity of these epithelial-like cells. Individual cells frequently abandoned the swiftly migrating
crowd by moving aside and crawling faster. The increasing mass of fast migrating epithelial-
like cells before and after mitosis confirmed the continuation of the cell cycle. In immunofluo-
rescence, analogously shaped cells expressed the p63 tumour marker, considered proof of
their origin from a carcinoma. These behavioural traits indicate the feasible identification of
carcinoma cells in culture according to the proposed concept of the carcinoma cell dynamic
phenotype. If further developed, this approach could later serve in a new functional online
analysis of reactions of carcinoma cells to therapy. Such efforts conform to current trends in
precision medicine.
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Jůzová V, Chmelı́k R, et al. (2017) Distinctive
behaviour of live biopsy-derived carcinoma cells
unveiled using coherence-controlled holographic
microscopy. PLoS ONE 12(8): e0183399. https://
doi.org/10.1371/journal.pone.0183399
Editor: Thomas Abraham, Pennsylvania State
Hershey College of Medicine, UNITED STATES
Received: December 20, 2016
Accepted: August 3, 2017
Published: August 28, 2017
Copyright: © 2017 Gál et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: Funded by The Ministry of Education,
Youth and Sports of the Czech Republic projects
CEITEC, 2020, ID number LQ1601; http://www.
msmt.cz/, RC; Nanofabrication and
Nanocharacterization Core Facility, CEITEC, ID
number LM2011020;https://www.ceitec.eu/, RC;
CZECH-BIOIMAGING: National Infrastructure for
Biological and Medical Imaging, ID number
Introduction
Cancer therapy is currently progressing towards the individualization of treatment guided by
evidence based on individual tumour properties [1]. Live cancer cells propagated in vitro from
biopsy have exemplified a plausible source of information for assessing solid tumour sensibility
to therapy. In addition, the attributes of these cells should also provide a contribution to the
prognosis [2]. Many chemosensitivity assays have been developed. Most of these assays rely on
an evaluation of the extent of cell death caused by the presence of an anticancer drug [3]. How-
ever, none of these methods have become part of clinical practice. In 2004, an American Society
of Clinical Oncology panel did not find sufficient evidence to support the routine use of in vitro
anticancer drug resistance tests and advocated the inclusion of these potentially important
research methods in prospective clinical trials. Since 2004, this situation has not changed. There
is no regular chemosensitivity or chemoresistance assay save for ovarian carcinoma, which,
based on current evidence, would be sufficient to support usage in oncology practice [4].
The in vitro motility of tumour cells is associated with the local invasiveness and metastatic
potential of experimental tumours in vivo [5,6]. Recently, Zhao et al. [7] also provided evidence
for salivary adenoid cystic carcinoma, reporting that the down-regulation of the microtubule-
associated tumour suppressor gene (MTUS1) expression contributes to the proliferation, migra-
tion and invasion abilities of this tumour as assayed in vitro. There are numerous methods to
evaluate cell motility in vitro under varying conditions. Nevertheless, the application of these
methods is limited, and their clinical impact remains minimal. However, the qualified exploita-
tion of the understanding of the regulation of migration and model invasiveness in vitro for the
examination of individual ex vivo cultured carcinoma cells remains crucial for progress in can-
cer diagnostics and therapy.
Our development of coherence-controlled holographic microscopy (CCHM) has offered us
an opportunity to examine the reactions of live cells. CCHM quantitative phase imaging
(QPI), which can be feasibly exploited even through turbid media [8] to measure tiny differ-
ences in cell motion [9], presents an innovative objective analysis of live cancer cells in vitro
achieved by simultaneously imaging the cell shape and position and measuring changes in the
cell mass, i.e., growth. Indeed, CCHM in a Q-PHASE microscope (Tescan Orsay Holding, a.s.,
Brno, Czech Republic) recently contributed to the differentiation of oncosis from apoptosis
[10] and the recognition of entosis, which emerged as a particularly important type of ostensi-
ble cell death but is potentially required for tumour survival [11].Head and neck squamous cell
carcinoma (HNSCC) is a pressing clinical problem. The available treatments based on a multi-
modal approach comprise surgery, chemotherapy, radiotherapy and biological therapy while
emphasizing organ preservation. HNSCC has been selected in the present study to examine
the promise of the CCHM method to contribute to clinical practice by the in vitro identifica-
tion of live carcinoma cells. If accomplished, these cells from individual tumour could subse-
quently be used in the screening for the best therapy option.
We acquired primary carcinoma cells from an HNSCC biopsy and employed molecular
biology to confirm their cancerous origin. Subsequently, we used CCHM QPI to recognize
behavioural traits. These efforts should further the current understanding of the in vitro identi-
fication of individual carcinoma live cells.
Materials and methods
Patient selection
We used three HNSCC tumours obtained from patients selected according to the inclusion
and exclusion criteria for the investigation of tumour biopsies in the present study, which was
approved by the FNUSA Ethical Commission.
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Inclusion criteria: biopsy proven; operable and inoperable; measurable stage III, IVA, IVB
squamous-cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx with no previ-
ous malignancy; age between 18 and 75 years; good performance status (WHO grade 0 – 1);
adequate laboratory tests (blood count and creatinine clearance); no symptomatic altered hear-
ing; no peripheral neuropathy grade 2; and informed consent.
Exclusion criteria: generalized disease and refusal to the patient to participate in the study.
Tumour biopsy
We obtained, within the framework of the diagnostic protocol, tumour samples using surgical
excision from the central part of the solid tumour tissue. We divided the volume of the approx-
imately 500-mm3 sample into halves. One half was used for regular histopathology examina-
tion. The other half was promptly transported in cold culture medium to the Cell Biology
Laboratory of the Experimental Biophotonics (CEITEC).
Cell culture
For the primary culture from biopsy, specimen cells were enzymatically released through
digestion in 0.05% collagenase A (Roche, Penzberg, Germany) or 0.25% trypsin (Sigma-
Aldrich, Prague, Czech Republic). We also cultivated cells outgrowing from tumour tissue
fragments. Plain TC plastic or glass-bottomed dishes were used as culture vessels. EMA med-
ium (a kind gift from Dr. Eva Matoušková) was H-MEM supplemented with non-essential
amino acids (Sigma-Aldrich, Prague, Czech Republic), 1 mM sodium pyruvate, 0.3 g/L L-glu-
tamine, 0.5 μg/ml hydrocortisone, 5 μg/ml insulin, 10−10 M cholera toxin, 5 ng/ml epidermal
growth factor (all these chemicals from Sigma-Aldrich, Prague, Czech Republic), 10% calf
serum (ZVOS Hustopece, Czech Republic) and 2% foetal bovine serum (Sigma-Aldrich,
Prague, Czech Republic), penicillin, and streptomycin [12]. The cells were fed either plain
EMA medium or EMA medium supplemented with 20% MEM and 10% calf serum condi-
tioned on semiconfluent NIH 3T3 cells for one day and subsequently centrifuged and filtered.
For time-lapse microscopy, the EMA medium was modified as follows: phenol red was omit-
ted, sodium bicarbonate concentration was lowered to one-third (0.3 g/L) and 20 mM of non-
volatile buffer TES (Sigma-Aldrich, Prague, Czech Republic) was added, and the pH set to 7.4.
We subsequently used the same media in the continuing cultivation of the isolated cells.
FaDu cell line (ATCC HTB-43) was established from a punch biopsy of a human hypophar-
yngeal tumour [13]. It is one of the most widely used HNSCC cell models and it is also a part
of ATCC Head and Neck Cancer Panel (ATCC TCP-1012). FaDu has been subjected to geno-
mic analysis and pharmacological profiling [14,15] and has already been used as a control for
newly established HNSCC cell line [16]. The established FaDu HNSCC cell line was main-
tained in standard culture medium (H-MEM with 5% foetal bovine serum).
Light microscopy
■ Nikon Eclipse TS100-F equipped with Zernike phase contrast LWD objectives for the reg-
ular assessment of the cell culture and static photography and short time-lapse recording
of ongoing cell morphological changes.
■ Olympus Bx41 with Olympus XM10 camera for fluorescence imaging.
■ NIKON confocal A1R for DIC and fluorescence imaging.
■ Q-PHASE multimodal holographic microscope (Tescan Orsay Holding, a.s., Brno, Czech
Republic) for the investigation of complex cell behaviour using the CCHM QPI method.
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SDS-PAGE and western blot
The cells were trypsinized, washed in PBS and resuspended in lysis buffer (150 mM NaCl, 1%
Nonidet P-40, 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, pH 8.0, and protease inhibitor cocktail).
The protein concentration was measured using a Bradford protein assay, and 20 μg of total
protein in the NuPAGE LDS Sample Buffer (Life Technologies, USA) was loaded onto 10%
polyacrylamide gels, separated and transferred onto nitrocellulose membranes using the Mini-
PROTEAN Electrophoresis System (Bio-Rad, USA) for 90 min, applying 100 V in the transfer
buffer (240 mM Tris, 190 mM glycine, and 20% methanol). The membranes were blocked in
5% non-fat milk in PBS with 0.1% Tween and incubated overnight with primary antibodies at
4˚C. Primary antibodies used: ΔNp63-1.1 (ΔNp63, Moravian Biotechnology, Czech Republic),
DC-10 (cytokeratin 18, Exbio, Prague, Czech Republic), DO-1 (p53, Moravian Biotechnology,
Czech Republic), NCL-L-EGFR (EGFR, Novocastra, UK), vimentin—Dako—Clone V9, E-
cadherin—Cell Signaling - 24E10, N-cadherin—Cell Signaling—D4R1H, AC40 (actin, Sigma-
Aldrich, USA). The membranes were subsequently incubated with HRP-conjugated secondary
antibody (RAM-Px, Dako, Denmark) for 1 h at room temperature. The signal was detected
using ECL reagent (Amersham Pharmacia Biotech, UK).
Immunofluorescence
The cells were grown on coverslips for 24 h, washed in phosphate-buffered saline (PBS) and
fixed in 4% formaldehyde in PBS for 20 min at room temperature. After washing in PBS, the
cells were permeabilized in 0.1% Triton X-100 in PBS for 5 min. To block the nonspecific
binding of the antibodies, cells were incubated with 3% bovine serum albumin (BSA) in PBS
for 20 min. The cells were incubated with diluted antibody in 3% BSA in PBS for 1 h at room
temperature. After 3 x 5 min washing with PBS, the cells were incubated with secondary anti-
body in 3% BSA in PBS for 1 h at room temperature in the dark. After 3 x 5 min wash with
PBS, the cell nuclei were stained with 1 μg/ml Hoechst for 5 min. The coverslips were mounted
with Vectashield H-1000 mounting medium (Vector Laboratories, USA) and stored in the
dark at 4˚C. Primary and secondary antibodies used: ΔNp63-1.1 (ΔNp63, Moravian Biotech-
nology, Czech Republic), SFI-6 (p63, DCS-Innovative Diagnostik-Systeme, Germany), MOC-
31 (EpCAM, Abcam, UK), and goat anti-mouse IgG DyLight-488 conjugate (Thermo Fisher
Scientific, USA).
Coherence-controlled holographic microscopy (CCHM)
The first diffraction order of the diffraction grating is separated in the reference arm to provide
a tilted off-axis reference beam and to ensure achromaticity and spatial invariance of the inter-
ferometer. Such a configuration equips CCHM QPI with the benefits of both spatially and
temporally incoherent illumination. CCHM incoherent light imaging improves the image
quality of QPI compared to coherent-illumination digital holographic microscopy (DHM)
[17] by suppressing coherence noise (speckles), interferences and diffraction artefacts, while
the lateral resolution is enhanced closer to standard light [17, 18]. The complete CCHM set-up
brings about the halo artefact suppression and an advantage of a single shot hologram registra-
tion with the CCD camera [17, 19]. All the factors mentioned contribute to the fast and sensi-
tive detection of cell outlines that enables reliable segmentation of cells making CCHM
particularly suitable for study of living cells dynamics.
To accommodate cells in Q-PHASE, we used various homemade or commercial (IBIDI,
Germany) observation chambers.
Image data processing. The Q-PHASE microscope produces holograms captured using a
CCD camera (Ximea MR4021MC-BH). Q-PHASE software provides the online reconstruction
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of phase shifts in radians into dry mass density (pg/µm2) [18, 20, 21]. The error range of mass
measurement was calculated on fixed cells under the same conditions and was approximately
1% of the total cell mass.
Cell cycle time estimation. Qualified estimation of the cell cycle time without the need of
measuring the whole cell cycle can be achieved by calculating the cell mass doubling time from
measuring the relative growth rate [22, 23]. Measurements of the cell mass increase lasting for
at least 3 hours are needed. Non-applicable situations, such as cells colliding with debris, small
fragments attached to the substratum, cells leaving the field of view or cells in mitosis, must be
excluded from data processing. In addition, situations in which the segmentation algorithm
fails while the cells crawl over or are in tight contact with each other are also excluded. Despite
the excluded data points, we could reliably fit the data and calculate the time that a cell poten-
tially requires to double its mass and presumably complete the cell cycle.
Cell migration. Migration trajectory and speed of migration for statistical analysis were
derived from localization of the mass centroid and its translocation. We measured the translo-
cation of the centre of the cell mass over 3 hours at five-minute interval between frames for the
centroid stabilization in order to avoid the error of accumulating small translocations pro-
duced through cellular in situ motility. We defined the migration trajectory as the sum of the
Euclidean distances between two following time points and actual speed from the length of the
partial trajectory.
Statistics
Student’s un-paired t-test was done using Matlab, MathWorks, Inc. and boxplot evaluation
was done using OriginPro 2016, OriginLab, Corp.
Results
Primary cultures from individual HNSCC
SACR1 tumour: Advanced squamous cell carcinoma of the hypopharynx, T3N2bM0, interme-
diate grade (G2), p53 neg. Patient: male, 64 years of age. SACR1 cells were harvested using col-
lagenase or trypsin digestion of the biopsy fragments. Within one week, some epithelial-like
cells, which mesenchymal-like cells later overgrew, were observed.
SACR2 tumour: Squamous cell carcinoma of the oral cavity, T2N0M0, intermediate grade
(G2), p53 neg. Patient: male, 73 years of age.
SACR2 cells were obtained after trypsinization and fragment culture. The primary cells
emerging from the tumour fragments gave rise to the only growing epithelial-like cell popula-
tion obtained (Fig 1A). Surprisingly, there were no fibroblast-like cells competing with the epi-
thelial-like cells, which were subsequently confirmed to originate from the carcinoma.
SACR3 tumour: Advanced squamous cell carcinoma of the oropharynx, T3N2aM0, high
grade (G3), p53 neg. Patient: male, 57 years of age.
SACR3 cells were derived from fragment cultures only. Reflecting problems with the insuf-
ficient attachment of fragments to the culture substratum, we harvested only some cells with
peculiar non-epithelial morphotypes.
Stationary characterization of live SACR2 cells. We selected SACR2 cells because of the
early epithelial-like morphology (Fig 1A) for further study and comparison with the estab-
lished HNSCC cell line FaDu [13]. SACR2 cells in culture showed an epithelial-like shape, and
on the population level, they expressed the p63 tumour marker of squamous cell carcinoma
(Fig 2A) [24, 25]. SACR2 cells in static observation of the dense layer appeared as tightly pac-
ked ordinary epithelial cells (Fig 1A, 1D and 1E). However, the morphology of the growing
colonies was irregularly shaped and jagged (Fig 1D and 1G), which differed from the ordinary
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roundish colonies of the HNSCC FaDu cells (Fig 3). The image of an actively migrating iso-
lated cell protruding into the free culture space followed by other cells provided a strong
impression of the collective invasion of carcinoma cells (Fig 1D and 1G, Fig 3). This notion
confirmed the short time-lapse observation that despite being taken only at lab temperature,
Fig 1. SACR2 cells early in culture. (A) Ex vivo fragment with outgrowing epithelial-like sheet of cells; (B) Ex
vivo fragment with individual cells dispersed around the fragment and mixed with tumour-associated ramified
macrophages that subsequently vanish. (C) Ex vivo fragment of healthy tissue from the vicinity of an SACR2
tumour with outgrowing mesenchymal cells. (D) Irregular shape of primary colonies. (E) Pleomorphic cell
phenotype in parts of a semi-confluent culture. (F) Variability of cell shapes in sparse culture. (G) Unusual
colony shapes invoking the impression of latent propensity to invasion. (H-K) active release within one hour of
an SACR2 cell from a projection of the colony at lab temperature. Scale bars, 50 µm.
https://doi.org/10.1371/journal.pone.0183399.g001
Fig 2. Western blots for tumour markers. (A) Comparison of FaDu with SACR2 cells shows high similarity
in p63, KRT18 and EGRF expression and an absence of p53 in SACR2 cells. (B) SACR2 cells compared with
FaDu cells show decreasing expression of E-cadherin with increasing passages (6th, 10th, 30th) and almost
the same expression of ΔNp63. Vimentin was expressed only in SACR1 and 3 cells, and N-cadherin was only
slightly expressed in SACR3 cells.
https://doi.org/10.1371/journal.pone.0183399.g002
Distinctive behaviour of live cancerous cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0183399 August 28, 2017 6 / 14
the active release of the leading cell from the colony projection (Fig 1H–1K) was observed
within one hour.
Western blots for tumour markers. SACR2, similar to FaDu cells, expressed p63, KT18,
EGFR, ΔNp63 and decreased expression of E-cadherin but not p53 (Fig 2A). SACR1 and
SACR3 expressed vimentin, which was not detected in FaDu or SACR2 cells. N-cadherin was
only marginally detected in SACR3 cells (Fig 2B). We considered confirmation of the p63
expression in the SACR2 cells as evidence of carcinoma origin [24, 25].
Dynamic CCHM QPI analysis of SACR2 cells. For CCHM, we investigated the SACR2
cells for dynamic morphology, motility as the ruffling of the leading cell periphery engaged in
migration and in cell-to-cell collisions. We measured these characteristics as related to cell
mass in two stages of SACR2 cells continuously cultured in vitro. The first stage was in the
fourth passage (55 days after seeding), when cells other than epithelial morphotypes could still
likely occur, e.g., fibroblasts and macrophages, as in primary culture (Fig 1B and 1C). The sec-
ond stage was in the ninth passage (110 days after seeding), and 48-hour time-lapse recording
provided substantial information on the nature of the SACR2 cells. Subsequently, when
defrosted from cells frozen after the sixth passage (after 120 days in culture, of which 53 days
were spent frozen in liquid nitrogen), SACR2 cells were examined for the stability of the
dynamic phenotype. In all instances, the patterns of SACR2 cell motility, migration and
growth, also indicated by mitotic activity, were similar. Fig 4 reviews SACR2 events of maxi-
mum migration speed and mitotic activity over a period of 48 hours of time-lapse recording at
8-sec intervals between frames. Within the field of view, we observed approximately one hun-
dred cells migrating individually or in a group there. Cell activity was evaluated in relationship
to the “social” situation of the cell. The maximum speed either achieved by cells, either single
Fig 3. Comparison between SACR2 epithelial cells (10th passage) and the FaDu HNSCC cell line.
Phase contrast: SACR2 cells still show an irregular shape, both in terms of cells and colonies, while polygonal
FaDu cells form regular rounded colonies. EpCAM and p63 are expressed in the individual cells of both
populations. Scale bars, 20 µM.
https://doi.org/10.1371/journal.pone.0183399.g003
Fig 4. Overview of SACR2 cell activities manifested over 48 hours of time-lapse recording at the 9th
passage (Q-PHASE, 10x objective lens, field of view 376 x 376 μm2, 8-sec intervals). Mitoses and the
measurement of short lasting maximum migration speed were recorded in relationship to the “social” situation
of the cell. From all 36 mitoses, 8 events were observed in single migrating cells (S), 16 events were observed
in cells at the edge of the moving group (E), and 12 events were observed inside the group (C).
https://doi.org/10.1371/journal.pone.0183399.g004
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or at the edge and leaving the moving crowd, reached almost 200 μm/h, which is approxi-
mately three times the speed of the group. This phenomenon indicates a type of random acti-
vation of migration activity in a part of the cell population. The observed cells produced 36
mitoses peaking between the 8th and 11th hour after onset. The duration of cell division varied
between 20 and 100 minutes. Precise measurement was complicated by a delay in the final sep-
aration of the daughter cells, which frequently remained connected after telophase through a
thin cable for some time during early G1. If mitoses were observed in subsequent quarters
throughout, then declining numbers were detected: 14, 9, 6, and 7. Such a declining trend in
mitotic activity and speed of migration apparently reflects a worsening of the nutritional
conditions.
SACR2 cells had a highly plastic shape with a notable mass profile, suggesting a raised cell
height (Fig 5C). They showed a ruffling periphery, even at 1-sec time lapse intervals, engaged
in rapid migration (Fig 5B). Within the field of view, cells were migrating individually or in a
group. Single moving cells repeatedly joined the group or actively broke the connection with
the group and accelerated away individually and repeatedly, often undergoing mitosis along
the way. When we measured the mass of such cells before and after mitosis, the continuing
gain in mass indicated growth and continuous cell cycling (Fig 5A). Homotypic collisions
between migrating cells led to a temporal cessation of undulation of both membranes, but only
in the area in contact between these cells. There were no signs of cells engaged in underlapping
or overlapping among the various cells examined.
Immunofluorescence for tumour markers. Epithelial-like morphotypes of SACR2 cells
were investigated for tumour markers using fluorescence microscopy. The individual appar-
ently migrating cells that in static picture of fixed cells showed ruffling of the cell leading
periphery were also positive for p63 (Figs 3 and 6). In particular, EpCAM membrane staining
(Fig 6C) in this type of cells also distinguished carcinoma cells from tumour-associated macro-
phages [24].
Comparison of SACR2 with FaDu cells. A comparison of SACR2 cells selected from 48
hours lasting follow up in the ninth passage with the FaDu cells time-lapsed for 66 hours at 1
minute interval is shown in Fig 7. When tracked, the length of the trajectories were near zero
for FaDu cells (Fig 7A), while that for SACR2 cells were up to 300 μm (Fig 7B). In Fig 7C, the
boxplot representation confirms a significantly higher average speed of migration of SACR2
(in the 9th passage) compared with FaDu cells (50 cells from each time-lapsed record). The
periods of highest speeds of SACR2 cells registered in Fig 4 lasted less than 3 hours and
Fig 5. SACR2 cells at the 9th passage. (A) Cell cycle measurement of a quickly migrating and dividing single cell.
The steady gain in mass of the mother and one daughter cell indicates continuous cell cycling (doubling time 13.7
hours). The red arrow shows the daughter cell in the cell cycle, captured in the red square in the (B) pseudo-
coloured quantitative phase image of the field of view. (C) The same cell is presented in quasi-3D of dry mass
density, suggesting increased cell height. Calibration bar is in pg/μm2. Scale bar, 50 μm.
https://doi.org/10.1371/journal.pone.0183399.g005
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therefore these cells cannot be considered here. Doubling time was calculated from the expo-
nential growth as the period of time that an individual cell potentially needs to double its mass
and presumably accomplish the cell cycle through mitosis (Fig 7D). The boxplot indicates the
shorter cell cycle time of SACR2 cells and thus apparently higher growth rate compared with
FaDu cells (45 cells from each time-lapsed record).
Fig 7. Comparison of SACR2 cells in the 9th passage with the FaDu cell line. (A, B) Migration trajectories
were defined as the sum of partial Euclidean distance measured for the translocation of the centre of the cell
mass. 50 cells over 3 hours sampled at 5-minute interval. (C) The boxplot compares migration speed, which is
significantly higher for SACR2 than FaDu cells. Data from A and B. (D) Doubling time was calculated from the
growth rate during the available time period for estimation of probable cell cycle time. The boxplot indicates
the shorter cell cycle time of SACR2 cells and thus apparently higher growth rate compared with FaDu cells.
45 cells sampled for 3hr at 5-minute interval for each culture. The dots in the boxes indicate the mean, the
centreline is the median, the top of the box is the 25th percentile, and the bottom of the box is the 75th
percentile. The whiskers indicate the 90th percentiles (5th and 95th), and the outliers are plotted (OriginPro
2016, OriginLab, Corp.). These differences between SACR2 and FaDu cell populations were statistically
significant; *** denotes P values <0.0005.
https://doi.org/10.1371/journal.pone.0183399.g007
Fig 6. SACR2 cells in sparse culture. (A) DIC image shows migrating individual cells. (B) The same cells are p63 positive.
(C) Peripheral EpCAM positivity of similar individual SACR2 cells (6th passage, thawed) surroung cell nucleus (DAPI) confirm
the difference of individual SACR2 epithelial cells from macrophages. Scale bars, 20 μm.
https://doi.org/10.1371/journal.pone.0183399.g006
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Discussion
We have used the technology of CCHM QPI for the evaluation of dynamic cell morphology
and migration simultaneously with the growth of ex vivo cultured SACR2 head and neck squa-
mous cell carcinoma cell population positive for p63.
SACR 1 and 3 had to be omitted for absence of p63 expression while expressing mesenchy-
mal cell marker vimentin (Fig 2).
The patterns of cell behaviour verified through tumour markers detected using immunocy-
tochemistry should eventually lead to the in vitro online identification of live carcinoma cells.
For SACR2 cells in static pictures, we first obtained an impression of the epithelial sheet of
cohesive cells (Fig 1A), which were similar to those of the FaDu cell line (Fig 3). The first
remarkable difference was the morphology of colonies with an invasion prone aspect (Fig 1D
and 1G, Fig 3) that could initiate metastasis. Western blots subsequently revealed the expres-
sion of the tumour marker p63 [25, 26] in SACR2 cells, similar to FaDu cells (Fig 2).
This impression changed when high motility and migratory activity were observed in time-
lapse recordings associated with mitoses and steadily increasing cell mass during migration.
Data describing the dynamics of SACR2 cell behaviour suggested that these events might rep-
resent an ongoing process related or identical to the epithelial-mesenchymal transition, indi-
cated by the intermediate phenotypes of the cells in transition [27]. We observed the loss of
some epithelial markers, such as decreasing E-cadherin, ΔNp63 and KT18, from SACR2 cells,
while not yet acquiring the mesenchymal marker vimentin (Figs 2, 3 and 6).
Nevertheless, instead of showing only the onset of migration expected around the edge of
the sheet of growing epithelial cells, we observed approximately one hundred growing and
dividing cells that moved as a group and individually back and forth. Single cells frequently
crawled for a short time at a rapid speed of almost up to 200 μm/h in a sideways manner,
which is typical for fast migrating epithelial-like fish keratocytes [28]. The increased mass den-
sity of these cells (Fig 5B) signified an elevated cell body, considered a marker of neoplastic
cells [29, 30]. The average speed was lower (Fig 7C) because of the 3-hour tracking of cells and
measuring of growth for the cell mass doubling time calculation (Fig 7D), indicating a shorter
cell cycle time for SACR2 cells than for FaDu cells (Fig 7D). This finding highlights the value
of using CCHM QPI observation of primary cultures from biopsy ex vivo as soon as possible
because it can accelerate the timely recognition of the true character of the observed cell popu-
lation. However, the absence of migration in FaDu cells is likely related to the expression of
epithelial markers. FaDu cells express p63 and p53, which is missing in SACR2 cells and in the
original tumour. In FaDu cells, there is more ΔNp63, E-cadherin and KT18. Th conceivable
confusion of an SACR2 cell with macrophages is eliminated not only by the regularity of cell
divisions but also by EpCAM expression on the surface (Fig 6C) of an apparently migrating
cell. This could also indicate that the oncogenic cleavage of EpCAM during the epithelial-mes-
enchymal transition [31] does not necessarily precede the onset of migration.
We suppose that capturing these patterns of cell behaviour was facilitated by the specific condi-
tions of the fragment culture, which offered a suitable attachment option to support emerging
mesenchymal traits in transitional cells. This observation could be considered a neglected advan-
tage of the decreasingly common 2D cell culture style. Fragment culture also has the potential to
uncover the heterogeneity of cells from an individual tumour and consider their interactions.
However, the conditions for primary tumour fragment culture still need significant improvement.
Using QPI, we observed and measured the suspected progeny of epithelial-like cells of car-
cinoma cells growing out from tumour tissue fragments. The cells exhibited mitoses, growth
and a high speed of migration. Using immunofluorescence, we detected tumour markers
expressed in individual analogous cell types. In addition to the epithelial and epithelial-
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mesenchymal transition markers, the expression of p63 appears to be the main evidence for
the neoplastic, and particularly HNSCC, origin of SACR2 [25, 32, 33, 34, 35, 36].
These findings suggested that CCHM QPI observation and measurement of carcinoma
biopsy cells in action revealed the following cancerous traits characterizing the proposed carci-
noma cell dynamic phenotype:
Highly changeable epithelial shape; elevated cell body; leading lamella rapid undulation;
rapid sideways crawling; fast migrating groups instead of a concentrically growing cell colony
or sheet; individually acting cells moving even faster than the group and heading in a different
direction while gaining mass and going through mitosis in cycles of separating from the group
and merging with it later; and preservation of the homotypic contact inhibition of locomotion.
All these traits of cell behaviour are amenable to change upon treatment with drugs. Conse-
quently, not only cell survival or death can be evaluated. This scenario deepens quality of test-
ing live cancer cells.
Conclusions
We understand that the results are first steps to the timely online identification of the carci-
noma cell dynamic phenotype achieved with the CCHM QPI method. The method in the next
step, will have to be validated by testing cells from malignant and benign tumours. Corre-
spondingly, the identification of cancerous cells through direct microscopic evaluation could
subsequently serve an endeavour to devise e.g. an early chemosensitivity test of individual
tumours or to validate migrastatics [37].
The recognition of cancerous cells from the dynamics of behavioural activity could bridge
the gap between wide genomic knowledge versus uncertainty on the resulting phenotype of
cancer cells [38]. Thus, this new understanding should promote progress in the envisaged
applications of precision medicine.
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Supervision: Břetislav Gál, Radim Chmelı́k, Pavel Veselý.
Validation: Břetislav Gál, Pavel Veselý.
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